Preface |
|
xi | |
About the Companion Website |
|
xiii | |
1 An Introduction to MOL Analysis of PDEs: Wave Front Resolution in Chromatography |
|
1 | (68) |
|
|
2 | (5) |
|
|
7 | (14) |
|
|
7 | (9) |
|
|
16 | (4) |
|
1.2.3 Subordinate routines |
|
|
20 | (1) |
|
1.3 Model output, single component chromatography |
|
|
21 | (32) |
|
|
21 | (18) |
|
1.3.2 Flux limiters, step BC |
|
|
39 | (9) |
|
|
48 | (2) |
|
1.3.4 Flux limiters, pulse BC |
|
|
50 | (3) |
|
1.4 Multi component model |
|
|
53 | (1) |
|
|
54 | (13) |
|
|
54 | (8) |
|
|
62 | (5) |
|
1.6 Model output, multi component chromatography |
|
|
67 | (1) |
|
|
68 | (1) |
2 Wave Front Resolution in VEGF Angiogenesis |
|
69 | (22) |
|
|
70 | (2) |
|
|
72 | (14) |
|
|
72 | (9) |
|
|
81 | (4) |
|
2.2.3 Subordinate routines |
|
|
85 | (1) |
|
|
86 | (2) |
|
2.3.1 Comparison of numerical and analytical solutions |
|
|
86 | (2) |
|
2.3.2 Effect of diffusion on the traveling-wave solution |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
89 | (2) |
3 Thermographic Tumor Location |
|
91 | (22) |
|
|
92 | (2) |
|
|
94 | (11) |
|
|
94 | (6) |
|
|
100 | (5) |
|
|
105 | (5) |
|
3.4 Summary and conclusions |
|
|
110 | (1) |
|
|
111 | (2) |
4 Blood-Tissue Transport |
|
113 | (32) |
|
|
114 | (1) |
|
|
115 | (14) |
|
|
115 | (4) |
|
|
119 | (9) |
|
4.2.3 Bessel function routine |
|
|
128 | (1) |
|
|
129 | (4) |
|
|
133 | (9) |
|
4.5 Conclusions and summary |
|
|
142 | (1) |
|
|
143 | (2) |
5 Two-Fluid/Membrane Model |
|
145 | (20) |
|
|
146 | (1) |
|
|
147 | (13) |
|
|
148 | (5) |
|
|
153 | (7) |
|
|
160 | (2) |
|
5.4 Summary and conclusions |
|
|
162 | (3) |
6 Liver Support Systems |
|
165 | (40) |
|
|
166 | (1) |
|
6.2 Patient ODE model routines |
|
|
167 | (7) |
|
|
167 | (5) |
|
|
172 | (2) |
|
|
174 | (2) |
|
|
176 | (4) |
|
|
177 | (1) |
|
6.4.2 Adsorption unit AU1 |
|
|
177 | (1) |
|
6.4.3 Adsorption unit AU2 |
|
|
178 | (1) |
|
|
179 | (1) |
|
6.5 Patient-ALSS ODE/PDE model routines |
|
|
180 | (15) |
|
|
180 | (8) |
|
|
188 | (7) |
|
|
195 | (1) |
|
6.7 Summary and conclusions |
|
|
196 | (4) |
|
Appendix - Derivation of PDEs for Membrane and Adsorption Units |
|
|
200 | (3) |
|
A.1 PDEs for Membrane Units |
|
|
200 | (2) |
|
A.2 PDEs for Adsorption Units |
|
|
202 | (1) |
|
|
203 | (2) |
7 Cross Diffusion Epidemiology Model |
|
205 | (22) |
|
|
205 | (2) |
|
|
207 | (11) |
|
|
207 | (8) |
|
|
215 | (3) |
|
|
218 | (6) |
|
7.3.1 ncase = 1, time-invariant solution |
|
|
218 | (2) |
|
7.3.2 ncase = 2, transient solution, no cross diffusion |
|
|
220 | (2) |
|
7.3.3 ncase = 3, transient solution with cross diffusion |
|
|
222 | (2) |
|
7.4 Summary and conclusions |
|
|
224 | (1) |
|
|
225 | (2) |
8 Oncolytic Virotherapy |
|
227 | (48) |
|
|
228 | (1) |
|
|
229 | (17) |
|
|
230 | (10) |
|
|
240 | (5) |
|
8.2.3 Subordinate routine |
|
|
245 | (1) |
|
|
246 | (27) |
|
8.4 Summary and conclusions |
|
|
273 | (1) |
|
|
274 | (1) |
9 Tumor Cell Density in Glioblastomas |
|
275 | (28) |
|
|
276 | (1) |
|
|
277 | (12) |
|
|
277 | (9) |
|
|
286 | (3) |
|
|
289 | (10) |
|
9.3.1 Output for ncase = 1, linear |
|
|
290 | (5) |
|
9.3.2 Output for ncase = 2, logistic |
|
|
295 | (1) |
|
9.3.3 Output for ncase = 3, Gompertz |
|
|
296 | (3) |
|
9.4 p-refinement error analysis |
|
|
299 | (2) |
|
9.5 Summary and conclusions |
|
|
301 | (1) |
|
|
301 | (2) |
10 MOL Analysis with a Variable Grid: Antigen-Antibody Binding Kinetics |
|
303 | (38) |
|
|
303 | (3) |
|
|
306 | (12) |
|
|
306 | (8) |
|
|
314 | (4) |
|
|
318 | (7) |
|
|
318 | (3) |
|
|
321 | (4) |
|
10.4 Summary and conclusions |
|
|
325 | (2) |
|
Appendix: Variable Grid Analysis |
|
|
327 | (13) |
|
A.1 Derivation of numerical differentiators |
|
|
327 | (4) |
|
A.2 Testing of numerical differentiators |
|
|
331 | (9) |
|
A.2.1 Differentiation matrix |
|
|
331 | (1) |
|
|
332 | (8) |
|
|
340 | (1) |
Appendices |
|
|
Appendix A Derivation of Convection-Diffusion-Reaction Partial Differential Equations |
|
|
341 | (4) |
|
Appendix B Functions dss012, dss004, dss020, vanl |
|
|
345 | (6) |
Index |
|
351 | |